A multi-institutional perspective of complication rates for elective nonreconstructive breast surgery: An analysis of NSQIP data from 2006 to 2010

Philip J. Hanwright, Elliot M. Hirsch, Akhil K. Seth, Geoffrey Chow, John Smetona, Colton McNichols, Jessica A. Gaido, Neil A. Fine, Karl Y. Bilimoria, John Y.S. Kim*

*Corresponding author for this work

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Background: As elective nonreconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on minor and major postoperative complications. Objective: The authors utilized a multi-institutional database to compare 30-day morbidities and reoperation rates among the different types of elective nonreconstructive breast surgery. Methods: Patients in the National Surgical Quality Improvement Program (NSQIP) participant use file who underwent elective nonreconstructive breast surgery between 2006 and 2010 were identified. Twenty defined morbidities were compared among mastopexy, reduction mammaplasty, and augmentation mammaplasty patients using analysis of variance and χ2 tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. Results: Of the 3612 patients identified, 380 underwent mastopexy, 2507 underwent reduction mammaplasty, and 725 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared with mastopexy and reduction mammaplasty (1.24%, 2.37%, and 4.47%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections, and wound disruptions (P < .05). Moreover, 30-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (1.58%, 2.07%, and 0.97%), as were the rates of life-threatening complications (0%, 0.16%, and 0%). One death was observed for all 3612 procedures (0.03%). Conclusions: Elective breast surgery is a safe procedure with an extremely low incidence of life-threatening complications and mortality. Comprehensive data collated from the NSQIP initiative add to the literature, and the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.

Original languageEnglish (US)
Pages (from-to)378-386
Number of pages9
JournalAesthetic surgery journal
Volume33
Issue number3
DOIs
StatePublished - Mar 1 2013

    Fingerprint

Keywords

  • NSQIP
  • augmentation mammaplasty
  • complications
  • cosmetic breast surgery
  • elective breast surgery
  • mastopexy
  • outcomes
  • reduction mammaplasty

ASJC Scopus subject areas

  • Surgery

Cite this